Racial/ethnic differences in drug disposition and response: review of recently approved drugs (Q38351175)

2 September 2017

1 reference

title

Racial/ethnic differences in drug disposition and response: review of recently approved drugs (English)

1 reference

2 September 2017

A Ramamoorthy

1

1 reference

2 September 2017

M A Pacanowski

series ordinal

2

1 reference

2 September 2017

J Bull

series ordinal

3

1 reference

2 September 2017

L Zhang

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

20 January 2015

1 reference

Clinical Pharmacology & Therapeutics

2 September 2017

1 reference

2 September 2017

97

1 reference

2 September 2017

263-273

1 reference

2 September 2017

3

1 reference

Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics

2 September 2017

1 reference

A review and assessment of potential sources of ethnic differences in drug responsiveness

21 January 2018

1 reference

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms

21 January 2018

1 reference

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

21 January 2018

1 reference

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

21 January 2018

1 reference

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

21 January 2018

1 reference

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors

21 January 2018

1 reference

Exploring differences in drug doses between Japan and Western countries

21 January 2018

1 reference

Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan

21 January 2018

1 reference

Assessment of factors associated with dose differences between Japan and the United States.

21 January 2018

1 reference

The impact of ethnicity on response to antihypertensive therapy

21 January 2018

1 reference

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis

21 January 2018

1 reference

Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel.

21 January 2018

1 reference

Emerging ethnic differences in lung cancer therapy

21 January 2018

1 reference

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin

21 January 2018

1 reference

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.

21 January 2018

1 reference

Ancestry and disease in the age of genomic medicine

21 January 2018

1 reference

Population structure of Hispanics in the United States: the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits.

21 January 2018

1 reference

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population

21 January 2018

1 reference

Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual...

21 January 2018

1 reference

Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map

21 January 2018

1 reference

Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice

21 January 2018

1 reference

7 January 2021

The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies

1 reference

7 January 2021

Ethnic differences in pharmacokinetics in new drug applications and approved doses in Japan

1 reference

7 January 2021

Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives

1 reference

7 January 2021

Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study

1 reference

7 January 2021

Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations

1 reference

7 January 2021

Identifiers

DOI

10.1002/CPT.61

1 reference

2 September 2017

1 reference